You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/india-novartis-challenges-patent-law-seeks-extended-protection-for-cancer-drug-saying-patents-save-lives-ngos-say-move-threatens-affordable-essential-medicines#c39794

Many lives at risk if drug company wins court case

Author: Arthur Okwemba, Daily Nation [Kenya], Published on: 30 January 2007

The cost of essential drugs could soon rise substantially, if a pharmaceutical giant [Novartis] wins a court case [in India] against patents that allow production of generics... A ruling in favour of the company will have far-reaching effects on HIV antiretroviral (ARV) drugs and other essential medicines commonly used in Kenya, and most of the developing world... “Our lives are at stake. If Novartis wins this case, we will roll back the gains made in access to cheap medicines. The company and other drug manufacturers should not put patents and profits before lives,” says Ms Monique Wanjala, who has lived with HIV for 13 years.

Read the full post here

Related companies: Novartis